Morand-Joubert L - Search Results

1

Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigen.

Morand-Joubert L, Costagliola D, Bludau H, Petit JC, Lefrère JJ. Morand-Joubert L, et al. J Acquir Immune Defic Syndr (1988). 1994 Jul;7(7):676-80. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8207645

2

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test.

Marot S, Bocar Fofana D, Flandre P, Malet I, Zafilaza K, Leducq V, Vivien D, Mrabet S, Poignon C, Calvez V, Morand-Joubert L, Marcelin AG, Gozlan J. Marot S, et al. Life (Basel). 2022 Dec 9;12(12):2064. doi: 10.3390/life12122064. Life (Basel). 2022. PMID: 36556429 Free PMC article.

3

Time to HIV seroconversion after needlestick injury.

Meyohas MC, Morand-Joubert L, Van de Wiel P, Mariotti M, Lefrère JJ. Meyohas MC, et al. Lancet. 1995 Jun 24;345(8965):1634-5. doi: 10.1016/s0140-6736(95)90139-6. Lancet. 1995. PMID: 7783549 No abstract available.

4

Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individuals.

Morand-Joubert L, Mariotti M, Reed D, Petit JC, Lefrere JJ. Morand-Joubert L, et al. Int J Cancer. 1995 Jan 17;60(2):156-9. doi: 10.1002/ijc.2910600203. Int J Cancer. 1995. PMID: 7829207

5

Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigen.

Morand-Joubert L, Bludau H, Lerable J, Petit JC, Lefrère JJ. Morand-Joubert L, et al. J Med Virol. 1995 Sep;47(1):87-91. doi: 10.1002/jmv.1890470116. J Med Virol. 1995. PMID: 8551265

6

Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma that is rich in HIV antibodies.

Lefrère JJ, Roudot-Thoraval F, Vittecoq D, Heshmati F, Audat F, Lerable J, Reed D, Petit JC, Burghoffer B, Morand-Joubert L. Lefrère JJ, et al. Transfusion. 1996 Aug;36(8):734-8. doi: 10.1046/j.1537-2995.1996.36896374379.x. Transfusion. 1996. PMID: 8780670

7

Full or partial seroreversion in patients infected by hepatitis C virus.

Lefrère JJ, Guiramand S, Lefrère F, Mariotti M, Aumont P, Lerable J, Petit JC, Girot R, Morand-Joubert L. Lefrère JJ, et al. J Infect Dis. 1997 Feb;175(2):316-22. doi: 10.1093/infdis/175.2.316. J Infect Dis. 1997. PMID: 9203652

8

Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.

Lefrère JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, Petit JC, Roudot-Thoraval F. Lefrère JJ, et al. Blood. 1997 Aug 1;90(3):1133-40. Blood. 1997. PMID: 9242545 Free article.

9

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.

Serfaty L, Chazouillères O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chrétien Y, Poupon RE, Petit JC, Poupon R. Serfaty L, et al. Hepatology. 1997 Sep;26(3):776-9. doi: 10.1002/hep.510260334. Hepatology. 1997. PMID: 9303512

10

Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology.

Lefrère JJ, Loiseau P, Maury J, Lasserre J, Mariotti M, Ravera N, Lerable J, Lefèvre G, Morand-Joubert L, Girot R. Lefrère JJ, et al. Blood. 1997 Nov 1;90(9):3776-80. Blood. 1997. PMID: 9345065 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters